JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Appendix 2 - Table of Immunisations

Deferral period The day of immunisation is Day 0.
Day 1 commences at one minute past midnight on the day after immunisation.

 

Diseases Protected against Comments and example trade names of adult preparations Minimum deferral period?*
Anthrax Rarely given Non-Live No
Cholera There are two vaccines available to prevent cholera: Dukoral® and Vaxchora®; see rows below. Ensure the correct guidance is applied depending on the vaccine given.
If vaccine name not certain, treat as a Live vaccine.
   
Vaxchora® Live 28 days
Dukoral® Non-Live No
COVID-19 (SARS-CoV-2) All COVID-19 vaccines licensed in the UK are Non-Live. Non-Live No
Dengue Qdenga®, Dengvaxia® Live 28 days
Haemophilus influenza type b (Hib) Menitorex® Non-Live No
Hepatitis A May be combined with typhoid or hepatitis B.
Hepatitis A only: Vaqta®, Avaxim®, Havrix®
Combined with typhoid: ViATIM®
Combined with hepatitis B: Ambirix®, Twinrix®
Non-Live 14 days
Hepatitis B May be combined with hepatitis A. If unexposed and more than 14 days from last immunisation, accept. See: Hepatitis B – Immunisation
Engerix®, Fendrix®, HBvaxPRO®, PreHevBri®, Ambirix®, Twinrix®
Non-Live 14 days
Human papillomavirus (HPV) Cervarix®, Gardasil® Non-Live No
Influenza, intra-nasal Live vaccine given by intra-nasal spray, age 2-18.
Fluenz Tetra®
Live 28 days
Influenza, injection Annual ‘flu jab’, given by injection.
Several preparations, updated annually.
Non-Live No
Japanese Encephalitis Travel. Ixiaro® Non-Live 14 days
Measles, Mumps, Rubella MMR vaccines. M-M-RvaxPro®, Priorix® Live 28 days
Meningitis Meningococcal group C: NeisVac-C®, Menjugate Kit®
Meningococcal group B: Bexsero®, Trumenba®
MenACWY Quadrivalent vaccine: Menveo®, Nimenrix®, MenQuadfi®
Combined with H. influenzae type b (Hib): Menitorix®
Non-Live No
Mpox (formerly known as Monkeypox) Imvanex® / MVA-BN is a live attenuated non-replicating Smallpox vaccine. It may be used for pre-exposure Mpox prophylaxis in healthcare workers or for post-exposure prophylaxis in contacts of Mpox cases. If given for Mpox vaccination, treat as a non-live vaccine.
See DSG entry for Mpox
Non-Live No
Pertussis Usually pregnant women, given in combination with Diphtheria, Tetanus and Polio vaccine or in combination with Diphtheria and Tetanus vaccine. Non-Live No
Pneumococcal disease Given to people with specific risks: for example, people who have had a splenectomy or people over 65. Pneumovax®23 Non-Live No
Polio, injected Given in combination with other vaccines including, depending on the preparation, Diphtheria, Tetanus, Pertussis and Haemophilus influenzae. Non-Live No
Polio, oral Not in routine use in UK. May be used abroad Live 28 days
Rabies Given to non-exposed individuals if occupation or activity has an exposure risk, or for some travellers to endemic areas.
Rabipur®, Verorab®
Non-Live No
Respiratory Syncytial Virus (RSV) Abrysvo®, Arexvy® Non-Live No
Shingles There are two vaccines available to prevent shingles: Zostavax® and Shingrix®; see rows below.
Please note, Shingrix® has replaced Zostavax® in the UK vaccination programme for individuals aged 60-79 years.
   
Zostavax® for shingles prevention Live 28 days
Shingrix® for shingles prevention Non-Live No
Smallpox Note this live vaccine requires an 8-week deferral. If given, see DSG entry for Smallpox Immunisation.
See also Mpox (above).
Live 56 days
Tetanus Given in combination with other vaccines including, depending on the preparation, Diphtheria, Tetanus, Pertussis and Haemophilus influenzae. Non-Live No
Tick-borne encephalitis (TBE) TicoVac® Non-Live No
Tuberculosis BCG vaccine Live 28 days
Typhoid, injected Typhim Vi®
Combined with hepatitis A: ViATIM®
Non-Live No
Typhoid, oral Given in capsule form. Vivotif® Live 28 days
Varicella (chickenpox) Usually given to healthcare workers. Varilrix®, Varivax® Live 28 days
Yellow Fever Stamaril® Live 28 days
* Minimum deferral period after immunisation if donor has not been exposed to the infection.
For immunisation post-exposure, refer to the relevant WB-DSG entry.

 

This page was last updated in WB-DSG Edition 203 Release 78.

 

Last updated 28/08/2025